Steven A. Shallcross - Jan 25, 2023 Form 4 Insider Report for Theriva Biologics, Inc. (TOVX)

Signature
/s/ Steven A. Shallcross
Stock symbol
TOVX
Transactions as of
Jan 25, 2023
Transactions value $
$21,825
Form type
4
Date filed
1/26/2023, 05:03 AM
Previous filing
Jan 23, 2023
Next filing
Feb 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TOVX Common Stock Purchase $21.8K +25K +18.52% $0.87 160K Jan 25, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $0.860 through $0.875, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.